Defective mismatch repair associated mutational signatures, a prognostic and predictive biomarker in endometrial cancer.
Yifan Chang(Yale University), Gary Altwerger(Yale New Haven Hospital), Wafa Khadraoui(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Naomi Adjei(The University of Texas MD Anderson Cancer Center)
Cited by 2
Related Papers
Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer
|JAMA Network Open|2023|41
“More than a song and dance”: Exploration of patient perspectives and educational quality of gynecologic cancer content on TikTok
|Gynecologic Oncology|2023|15
Port-Site Metastasis in Gynecological Malignancies
|JSLS Journal of the Society of Laparoscopic & Robotic Surgeons|2021|11
ISG15 mediates the function of extracellular vesicles in promoting ovarian cancer progression and metastasis
|Journal of Extracellular Biology|2024|11
Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites
|Gynecologic Oncology Reports|2021|10